secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oscar Health, Inc. (OSCR)
CIK:        0001568651
Form:       8-K
Filed at:   2026-08-06T10:08:21+00:00
Accession:  0001568651-26-000066
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oscar Health Q2 net income $361.8M vs loss $228.4M; raises FY 2026 guidance
---------------------------------------------------------------------------

- Q2 2026 total revenue $4.88B, up 70% YoY; net income $361.8M ($1.10 diluted EPS) vs net loss $228.4M ($0.89 loss) in Q2 2025.
- Medical loss ratio improved to 79.2% from 91.1%; SG&A expense ratio improved to 14.2% from 18.7%.
- Effectuated membership grew 46% YoY to 2.96M members.
- Full-year 2026 earnings from operations guidance raised to $500M-$700M (from $250M-$450M); MLR guidance improved to 81.5%-82.5%.
- Adjusted EBITDA $415.3M in Q2 2026 vs loss $199.4M in Q2 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1568651/000156865126000066/0001568651-26-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1568651/000156865126000066/oscr-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001568651-26-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer